Amicus Therapeutics (FOLD) remains a Buy, driven by strong product momentum and new assets. Read here for more investment ...
Unifying global IP rights and enabling up to $5 million in potential shareholder contributions, the agreement strengthens Telomir’s foundation for partnerships, licensing, and long-term value creation ...
An India-based pharmaceuticals firm selling in the U.S. for 25 years has chosen Atlanta for a $200 million bet on American ...
Maryland-based Shuttle Pharmaceuticals Holdings intends to acquire Molecule.ai, a platform built to teach AI how to reason ...
UCTT has rallied higher in the past half year, but there are several reasons why the stock may find it harder to continue ...
ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Every generation has its frontier. For the last century, medicine's remained molecular: genes, proteins, receptors, the invisible mechanics of life ...
ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug ...
The FDA’s recent barrage of letters calling out alleged violatio | The FDA’s recent barrage of letters calling out alleged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results